ARTerial EMbolization for haemorrhoIdal Disease (ART.EM.I. Study)

Haemorrhoidal Bleeding Clinical Trial

— ARTEMIS  

Official title:

ARTerial EMbolization for haemorrhoIdal Disease Study

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT04684251
• Other study ID #: 12397
• Status: Withdrawn
• Phase: N/A
• Start date: November 25, 2020
• Est. completion date: May 24, 2022

Study information

• Verified date: August 2022
• Source: Oxford University Hospitals NHS Trust
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Haemorrhoidal disease is amongst the most common rectal conditions causing significant distress to the affected patients. Current surgical techniques for the treatment of internal haemorrhoids are associated with several drawbacks and sometimes high recurrence rates. The purpose of this study is to assess the safety and efficacy of a new minimally invasive technique that is based on blocking the arteries that feed the haemorrhoids and thus potentially leading to a decrease in their size. A recently published paper with 14 patients showed good results in terms of safety(Vidal et. al.). Despite the promising preliminary evidence, there is still a need for more studies and additional data. Furthermore, at the current time, there are no studies assessing quality of life changes post embolisation for these patients and the investigators hope to evaluate this important aspect of treatment as well.

This study will provide the investigators with results regarding the efficacy and safety of arterial embolisation for advanced haemorrhoid disease. This will be the first study to provide data on short and long term efficacy (in terms of re-bleeding and re-operation rates) as well as to provide evidence on the effect of this novel treatment on quality of life. This study will also be the largest study to date and if successful will pave the way for a large randomised controlled trial comparing the gold standard surgical treatment to the embolisation treatment.

The embolisation of haemorrhoid vessel is not an experimental technique and it has been used in the past in cases of uncontrollable hemorrhoidal- related bleeding with good results and without morbidity. However, this is the first time that the investigators will use this technique as a first line treatment for haemorrhoids and part of this study is to assess the feasibility and safety of this approach.

Description:

This is a pilot, prospective, single arm and single centre trial to assess the safety and efficacy of haemorrhoid embolisation. Patients with advanced hemorrhoidal disease (grade II-IV) will be identified through the colorectal clinic with a recruitment target of 24 patients. The duration of patient participation in this study is 24 months. During this time the patient will have to attend 4 appointments (including the treatment session).

All cases in this study will be performed as day case procedures. The patients will be admitted to the interventional radiology day unit in the morning, where a standard pre-assessment will take place. The main intervention will be the embolisation of their hemorrhoidal arteries. The embolisation will be performed using a standard approach with a right femoral puncture and after inserting a 5 Fr introducer sheath. The inferior mesenteric artery will be catheterized using a Simmons catheter (radiofocus-Terumo). The superior rectal arteries will be then catheterized with a rapid transit microcatheter Progreat microcatheter (Radiofocus-Terumo) and then embolised with a number of coils. The arteries will be packed with coils until there is complete blood flow stasis within the target artery bilaterally. The technical success of the procedure will be assessed by achieving stasis of blood flow distally to the site of the embolisation. This will be assessed fluoroscopically. CE marked coils will be used for the embolisation of the arteries feeding the haemorrhoids.

Following the procedure, patients will be discharged to their usual place of residence after 6 hours of observations in the interventional radiology day unit. The patients will be followed up in the colorectal clinic after 3 months, 12 months and 24 months.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: May 24, 2022
• Est. primary completion date: May 24, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 40 Years to 90 Years

Eligibility

Inclusion Criteria:

i. Adult male and female patients between the ages of 40-90 years old.

ii. Patients with grade II-IV haemorrhoid disease with re-current or active bleeding AND

iii. Patients with (ii) who do not wish to undergo surgery for their symptoms OR

iv. Patients with (ii) despite previous surgery.

v. Patients who can understand and sign the consent form.

Exclusion Criteria:

i. Patients who are not otherwise fit for surgery.

ii. Patients with significant ano-rectal comorbidities (cancer, fistula, abscesses).

iii. Patients who are unable to sign the inform consent form.

iv. Pregnancy.

v. Patients with history of significant colorectal disease or previous colectomy.

vi. Iodine allergy/ Contrast allergy.

Related Conditions & MeSH terms

• Haemorrhoidal Bleeding

Intervention

Procedure:
• Coil embolisation of hemorrhoidal arteries.
Coil embolisation of hemorrhoidal arteries as previously described.

Locations

Country	Name	City	State
United Kingdom	Department of Interventional Radiology, John Radcliffe Hospital	Oxford

Sponsors (1)

Lead Sponsor	Collaborator
Oxford University Hospitals NHS Trust

Country where clinical trial is conducted

United Kingdom, 

References & Publications (2)

Nyström PO, Qvist N, Raahave D, Lindsey I, Mortensen N; Stapled or Open Pile Procedure (STOPP) trial study group. Randomized clinical trial of symptom control after stapled anopexy or diathermy excision for haemorrhoid prolapse. Br J Surg. 2010 Feb;97(2):167-76. doi: 10.1002/bjs.6804. — View Citation

Vidal V, Louis G, Bartoli JM, Sielezneff I. Embolization of the hemorrhoidal arteries (the emborrhoid technique): a new concept and challenge for interventional radiology. Diagn Interv Imaging. 2014 Mar;95(3):307-15. doi: 10.1016/j.diii.2014.01.016. Epub 2014 Feb 28. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To assess the clinical success of the procedure	Resolution of symptoms 1 year after operation is the primary endpoint. This will be assessed with a previously validated patient questionnaire of bowel function (Nyström et. al.). Five questions about haemorrhoidal symptoms will be appended while retaining the structure of the questionnaire. Patients will also submit a health-related quality-of-life questionnaire (SF-12 Form). Questionnaires will be completed before the operation, at 3, 12 and 24 months follow-up.	Pre-operative (day of procedure) 3, 12, and 24 months post-operatively
Secondary	To assess the technical success of the procedure	The technical success of the procedure will be assessed by achieving stasis of blood flow distally to the site of the embolization. This will be assessed fluoroscopically.	Day of procedure (immediately at time of procedure)
Secondary	To assess the safety of the procedure and potential side effects	Post-operative pain will be recorded by the patient after operation. The pain experienced during most of the day and a peak pain will be recorded straight after the procedure and using a ten point visual analogue scale (VAS) (0, no pain; 10, worst pain imaginable). Side effects and potential complications related to the procedure will be documented in the case report form.	Immediately post-procedure, 3, 12 and 24 months post-operatively